coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials
With the dramatic increase in the pipeline for new sickle cell disease (SCD) therapies in recent years, the time is ripe to ensure a robust body of evidence is available for decision making by regulators, paye...